Metastatic Biliary Tract Cancers (SUMMIT - Neratinib Basket Trial, 2022)

Summary

Metastatic Biliary Tract Cancers (SUMMIT - Neratinib Basket Trial, 2022) is a study catalogued by cBioPortal DataHub under the cancer-type code biliary_tract. EvidenceHelix groups it with liver, bile duct and gallbladder studies.

Study description

Targeted sequencing of 25 advanced biliary tract cancers and their matched normals.

Text as published in the source's study metadata.

Citation & PubMed

The source lists no citation or PubMed id for this study.

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

biliary_tract_summit_2022

Short name

not given

Source cancer-type code

biliary_tract

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

The source lists no citation or PubMed id for this study.

Related studies

• Ampullary Carcinoma (Baylor College of Medicine, Cell Reports 2016)

  Exome sequencing analysis of 160 cancers arising in the periampullary region, 62 of these clearly arising from either the bile duct (n = 44) or the duodenum (n = 18) and 98 for which the epithelium of origin could not…

  Liver, bile duct and gallbladderOther published and consortium studiesSource code ampcaPubMed 1

• Cholangiocarcinoma (ICGC, Cancer Discov 2017)

  Whole-exome sequencing and Targeted/Exome sequencing of 489 Cholangiocarcinoma samples from 10 countries.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (National Cancer Centre of Singapore, Nat Genet 2013)

  Whole exome sequencing of 15 cholangiocarcinoma cases.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (National University of Singapore, Nat Genet 2012)

  Exome Sequencing for Opisthorchis viverrini-related cholangiocarcinoma in 8 O.viverrini-related tumors and matched normal tissue.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Combined Hepatocellular and Intrahepatic Cholangiocarcinoma (Peking University, Cancer Cell 2019)

  Whole-exome sequencing of 121 combined hepatocellular and intrahepatic cholangiocarcinoma (cHCC-ICC) patients with matched normal pairs (whole-genome sequenced samples are not included here).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccihchPubMed 1

• Gallbladder Carcinoma (Shanghai, Nat Genet 2014)

  Whole exome sequencing of 32 gallbladder carcinoma tumor/normal pairs.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code gbcPubMed 1

• Hepatocellular Adenoma (INSERM, Cancer Cell 2014)

  Whole-exome sequencing of 46 liver tumor/normal pairs.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code liadPubMed 1

• Hepatocellular Carcinoma (CLCA, Nature 2024)

  The Chinese Liver Cancer Atlas (CLCA) project. Deep whole-genome sequencing of 494 hepatocellular carcinomas and their matched normals. Data from CLC Atlas (http://lifeome.net:8080/clca/#/).

  Liver, bile duct and gallbladderOther published and consortium studiesSource code hccPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.